Magali Droniou Appointed General Director of METHYS Dx

29/06/2023 – Magali Droniou, PhD, Chief Operating Officer at METHYS Dx, was appointed General Director by the company’s shareholders on June 29, 2023.

Magali Droniou brings to METHYS Dx a unique expertise at the intersection of scientific research, technological innovation, and strategic development. PhD in molecular biology, she has led an international academic research career in the United Kingdom and the United States. She co-founded Stilla Technologies in 2013, where she played a key role in the development and commercialization of next-generation digital PCR technologies. Building on this entrepreneurial experience, she served as Director of Business Operations and Technology Transfer at SATT Lutech, where she contributed to the valorization of numerous innovations from public research.

Together with METHYS Dx President Valérie Taly, she will lead the company’s strategy and growth, with the ambition of transforming scientific advances into tangible solutions to improve care for cancer patients.